Lenvatinib-induced severe generalized erythematous rash in a patient with hepatocellular carcinoma. Dermatol Reports [Internet]. 2022 Dec. 29 [cited 2025 Jun. 19];15(2). Available from: https://journals.pagepress.org/dr/article/view/9617